Cargando…
Who are the real high-risk patients with pathological T2N0M0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy?
BACKGROUND: The benefit of adjuvant chemotherapy (ACT) in pathological T2N0M0 non-small-cell lung cancer (NSCLC) patients is not clear. METHODS: One thousand and fifty pathological T2N0M0 NSCLC patients were included and divided into two groups: with and without ACT. A propensity score matching anal...
Autores principales: | Hou, X., Yang, M.-Z., Li, J.-B., Tan, Z.-H., Long, H., Fu, J.-H., Zhang, L.-J., Lin, P., Yang, H.-X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184557/ https://www.ncbi.nlm.nih.gov/pubmed/35688064 http://dx.doi.org/10.1016/j.esmoop.2022.100508 |
Ejemplares similares
-
Exchange bias effect in polycrystalline Bi(0.5)Sr(0.5)Fe(0.5)Cr(0.5)O(3) bulk
por: Li, S. Z., et al.
Publicado: (2023) -
The $\pi^{0}\eta\eta^{\prime}$ mixing and CP violation in the $K^{0} \rightarrow \pi^{0}\pi^{0}$ mode
por: Li, X, et al.
Publicado: (1988) -
Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021) -
Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023) -
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)